FAHD1
Basic information
Region (hg38): 16:1826967-1840207
Previous symbols: [ "C16orf36" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FAHD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 9 | |||||
Total | 1 | 1 | 24 | 0 | 1 |
Highest pathogenic variant AF is 0.000112
Variants in FAHD1
This is a list of pathogenic ClinVar variants found in the FAHD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-1827384-A-G | not specified | Uncertain significance (Aug 05, 2024) | ||
16-1827407-C-A | not specified | Uncertain significance (Oct 26, 2021) | ||
16-1827410-A-G | not specified | Uncertain significance (Oct 25, 2023) | ||
16-1827422-A-C | not specified | Uncertain significance (Dec 16, 2023) | ||
16-1827425-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
16-1827469-G-C | not specified | Uncertain significance (Dec 23, 2022) | ||
16-1827483-T-A | not specified | Uncertain significance (Aug 02, 2023) | ||
16-1827528-G-C | not specified | Uncertain significance (Mar 01, 2023) | ||
16-1827552-T-C | not specified | Uncertain significance (Oct 17, 2023) | ||
16-1827594-C-A | not specified | Uncertain significance (Feb 16, 2023) | ||
16-1827617-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
16-1827681-A-G | not specified | Uncertain significance (Jul 26, 2024) | ||
16-1827737-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
16-1827746-A-C | not specified | Uncertain significance (May 30, 2024) | ||
16-1827746-A-G | not specified | Uncertain significance (May 02, 2024) | ||
16-1827753-A-G | not specified | Uncertain significance (Nov 29, 2021) | ||
16-1827771-C-G | not specified | Uncertain significance (Oct 25, 2022) | ||
16-1827783-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
16-1827783-G-T | not specified | Uncertain significance (Dec 07, 2021) | ||
16-1827815-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
16-1827848-G-A | not specified | Uncertain significance (Nov 14, 2023) | ||
16-1827852-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
16-1834265-T-G | not specified | Uncertain significance (Sep 22, 2023) | ||
16-1834352-G-T | not specified | Uncertain significance (Jul 29, 2023) | ||
16-1834363-C-G | not specified | Uncertain significance (Feb 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FAHD1 | protein_coding | protein_coding | ENST00000382666 | 2 | 13241 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.95e-12 | 0.00240 | 125621 | 0 | 108 | 125729 | 0.000430 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.84 | 198 | 137 | 1.44 | 0.00000630 | 1599 |
Missense in Polyphen | 51 | 40.938 | 1.2458 | 469 | ||
Synonymous | -1.71 | 76 | 59.3 | 1.28 | 0.00000293 | 509 |
Loss of Function | -2.29 | 14 | 7.32 | 1.91 | 3.11e-7 | 96 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00247 | 0.00246 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00115 | 0.00114 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000274 | 0.000273 |
Middle Eastern | 0.00115 | 0.00114 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probable mitochondrial acylpyruvase which is able to hydrolyze acetylpyruvate and fumarylpyruvate in vitro (PubMed:15551868, PubMed:21878618). Also has oxaloacetate decarboxylase activity (PubMed:25575590). {ECO:0000269|PubMed:15551868, ECO:0000269|PubMed:21878618, ECO:0000269|PubMed:25575590}.;
- Pathway
- Tyrosine metabolism - Homo sapiens (human);Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- loftool
- 0.254
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.2
Haploinsufficiency Scores
- pHI
- 0.124
- hipred
- N
- hipred_score
- 0.177
- ghis
- 0.441
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.879
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fahd1
- Phenotype
Gene ontology
- Biological process
- tricarboxylic acid cycle
- Cellular component
- nucleoplasm;mitochondrion;mitochondrial matrix;cytosol
- Molecular function
- oxaloacetate decarboxylase activity;acetylpyruvate hydrolase activity;fumarylpyruvate hydrolase activity;metal ion binding;acylpyruvate hydrolase activity